Tzu-Rong Peng - Search Results

Year	Number of Results
2014	1
2016	1
2017	2
2018	1
2019	2
2020	3
2021	10
2022	11
2023	7
2024	3

1

Effectiveness of Oil Pulling for Improving Oral Health: A Meta-Analysis.

Peng TR, Cheng HY, Wu TW, Ng BK. Peng TR, et al. Healthcare (Basel). 2022 Oct 11;10(10):1991. doi: 10.3390/healthcare10101991. Healthcare (Basel). 2022. PMID: 36292438 Free PMC article. Review.

2

Blinatumomab-Associated Elevation of Liver Enzymes.

Peng TR, Cheng HY, Chan CH, Chen HF, Kao WY. Peng TR, et al. Am J Ther. 2023 Jan-Feb 01;30(1):e83-e84. doi: 10.1097/MJT.0000000000001348. Epub 2021 Feb 15. Am J Ther. 2023. PMID: 36608074 No abstract available.

3

Lenvatinib-Associated Fulminant Type 1 Diabetes Mellitus.

Liao PF, Peng TR, Wu TW, Hu YH. Liao PF, et al. Among authors: peng tr. Am J Ther. 2023 Nov-Dec 01;30(6):e561-e563. doi: 10.1097/MJT.0000000000001495. Epub 2022 Mar 24. Am J Ther. 2023. PMID: 37921683 No abstract available.

4

Effects of various treatments for preventing oral mucositis in cancer patients: A network meta-analysis.

Peng TR, Tsai FP, Wu TW. Peng TR, et al. PLoS One. 2022 Dec 8;17(12):e0278102. doi: 10.1371/journal.pone.0278102. eCollection 2022. PLoS One. 2022. PMID: 36480513 Free PMC article.

5

Hypnotics and Risk of Cancer: A Meta-Analysis of Observational Studies.

Peng TR, Yang LJ, Wu TW, Chao YC. Peng TR, et al. Medicina (Kaunas). 2020 Oct 1;56(10):513. doi: 10.3390/medicina56100513. Medicina (Kaunas). 2020. PMID: 33019585 Free PMC article. Review.

6

Efficacy and safety of anaplastic lymphoma kinase inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis.

Peng TR, Liao PF, Wu TW. Peng TR, et al. Thorac Cancer. 2023 Apr;14(10):929-939. doi: 10.1111/1759-7714.14824. Epub 2023 Mar 13. Thorac Cancer. 2023. PMID: 36908264 Free PMC article.

7

Suspected ketamine-associated lower urinary tract symptoms.

Peng TR, Lee MC, Wu TW, Lan CC. Peng TR, et al. Urol J. 2014 May 7;11(2):1508-10. Urol J. 2014. PMID: 24807773 Free article. Review. No abstract available.

8

Efficacy and Safety of Programmed Death-1/Programmed Death-Ligand 1 Inhibitor for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.

Liao PF, Wang PY, Peng TR. Liao PF, et al. Among authors: peng tr. Curr Oncol. 2023 Nov 17;30(11):9940-9952. doi: 10.3390/curroncol30110722. Curr Oncol. 2023. PMID: 37999142 Free PMC article. Review.

9

The Experience of Management of High-Alert Medications.

Peng TR, Wu TW. Peng TR, et al. Am J Med Qual. 2017 Sep/Oct;32(5):571. doi: 10.1177/1062860617699699. Am J Med Qual. 2017. PMID: 28862027 No abstract available.

10

Monoclonal Antibodies for First-Line Treatment Metastatic Colorectal Cancer.

Liao PF, Wu TW, Peng TR. Liao PF, et al. Among authors: peng tr. Am J Ther. 2022 Aug 15. doi: 10.1097/MJT.0000000000001547. Online ahead of print. Am J Ther. 2022. PMID: 35972911

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

35 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year